Steady-State Pharmacokinetics of Etravirine and Lopinavir/Ritonavir Melt Extrusion Formulation, Alone and in Combination, in Healthy HIV-Negative Volunteers-Reference-Cited by-同舟云学术

Steady-State Pharmacokinetics of Etravirine and Lopinavir/Ritonavir Melt Extrusion Formulation, Alone and in Combination, in Healthy HIV-Negative Volunteers

Published:2013-01-24 Issue:2 Volume:53 Page:202-210
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:J Clin Pharmacol

Author:

Schöller-Gyüre Monika¹,Kakuda Thomas N.²,Witek James²,Akuma Sophie H.¹,Smedt Goedele De¹,Spittaels Kurt¹,Vyncke Veerle¹,Hoetelmans Richard M.W.¹

Affiliation:

1. Tibotec BVBA; Beerse; Belgium

2. Tibotec Inc; Titusville, NJ; USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference25 articles.

1. http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf

2. Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA Panel;Thompson;JAMA,2010

3. Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-1: 24-week results from a randomised, double-blind, placebo-controlled trial;Madruga;Lancet,2007

4. Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-2: 24-week results from a randomised, double-blind, placebo-controlled trial;Lazzarin;Lancet,2007

5. Efficacy and safety of etravirine in treatment-experienced, HIV-1 patients: pooled 48 week analysis of two randomized, controlled trials;Katlama;AIDS,2009

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigation of etravirine uptake and distribution in single aortic endothelial cells in vitro using Raman imaging;The Analyst;2024

2. Leveraging physiologically based pharmacokinetic modeling to optimize dosing for lopinavir/ritonavir with rifampin in pediatric patients;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2022-06-08

3. Successful Prediction of Human Fetal Exposure to P-Glycoprotein Substrate Drugs Using the Proteomics-Informed Relative Expression Factor Approach and PBPK Modeling and Simulation;Drug Metabolism and Disposition;2021-08-23

4. Safety and Pharmacokinetics of Double-Dose Lopinavir/Ritonavir + Rifampin Versus Lopinavir/Ritonavir + Daily Rifabutin for Treatment of Human Immunodeficiency Virus–Tuberculosis Coinfection;Clinical Infectious Diseases;2021-02-09

5. Physiologically‐Based Pharmacokinetic Modeling to Predict the Clinical Efficacy of the Coadministration of Lopinavir and Ritonavir against SARS‐CoV‐2;Clinical Pharmacology & Therapeutics;2020-10-06